Mizuho Securities analyst, Irena Koffler, reiterated her Neutral rating on shares of Eagle Pharmaceuticals (NASDAQ: EGRX) along with her price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE